The treatment of Age Spots & Cataracts with vitamins

Age Spots and Cataracts: Mitamins custom make quality formulas for the treatment of Age Spots & Cataracts with vitamins. A Age Spots & Cataracts formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Age Spots and Cataracts

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    500
    mg
    833%
    Vitamin D
    200
    IU
    50%
    Vitamin E
    200
    IU
    667%
    Thiamin
    50
    mg
    3333%
    Riboflavin
    75
    mg
    4412%
    Niacin
    50
    mg
    250%
    Vitamin B6
    50
    mg
    2500%
    Folate
    400
    mcg
    100%
    Vitamin B12
    125
    mcg
    2083%
    Pantothenic Acid
    100
    mg
    1000%
  • Amount Per Serving
    % DV
    Calcium
    100
    mg
    10%
    Magnesium
    50
    mg
    13%
    Selenium
    200
    mcg
    286%
    Alpha Lipoic Acid
    50
    mg
    *
    Lecithin
    100
    mg
    *
    Lutein
    6000
    mcg
    *
    Bilberry Extract
    50
    mg
    *
    Ginkgo Extract
    40
    mg
    *
    Grape Seed Extract
    25
    mg
    *
    L-Carnitine
    250
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Age Spots and Cataracts Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
FDA Accepts Sucampo's SNDA For Lubiprostone (8 Mcg) For The Treatment Of Irritable Bowel Syndrome With Constipation (IBS-C)
Sucampo Pharmaceuticals, Inc., (Nasdaq: SCMP) announced that the supplemental New Drug Application (sNDA) for lubiprostone (8 mcg, oral gel capsules, twice daily) for the treatment of irritable bowel syndrome with constipation (IBS-C) has been accepted for review by the U.S. Food and Drug Administration (FDA). Sucampo Pharmaceuticals currently anticipates a decision from the FDA in the second quarter of 2008.
Histogenics NeoCart Cartilage Therapy Found Promising In OHSU Study Crawford To Report Data At ICRS Meeting
Histogenics' NeoCartĀ® neocartilage implant is safe and shows promise, according to Dennis Crawford, MD, PhD, of Oregon Health & Science University (OHSU) in a presentation at the International Cartilage Repair Society Annual Meeting (ICRS) in Warsaw, Poland on September 30, 2007.
This information concerning the support of Age Spots and Cataracts treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments